NKTR
Nektar Therapeutics
stockNASDAQ
At CloseOct 2, 2026 3:59:51 PM EDT
43.66USD-7.087%(-3.33)2,923,413
Pre-marketOct 2, 2026 9:27:30 AM EDT
47.10USD+0.234%(+0.11)
After-hoursOct 2, 2026 4:39:30 PM EDT
43.58USD-0.183%(-0.08)
Loading…
Loading…
1.49B
Healthcare
Biotechnology
CEO
Howard Robin
HQ
San Francisco, CA, USA
509
Previous Close
$46.99
Beta
1.06
52-Week High
$109.00 2026-04-20
52-Week Low
$33.40 2026-01-30
SMA 50
$69.48
SMA 200
$65.41
Avg. Vol 10D
2.50M
Avg. Vol 30D
1.38M
Avg. Vol 90D
1.09M
Relative Vol
2.13
34.14M
29.14M
85.35%
5,735,633
19.68%
7.57
54%/46%
48.19%
33.82%
0.3100%
3,200,000
5,168
5,409
9,090
Nov 5, 2026 (31d)
Jun 9, 2025 · 1-for-15 (reverse)
Oct 2, 2026
Oct 1, 2026
Nektar drops after new mid-stage trial data for hair loss drug · 
Seeking Alpha
Nektar Therapeutics (NKTR) Shareholder/Analyst Call Transcript · Seeking Alpha
NKTR Profile
nektar therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. nektar also partners with the top biopharmaceutical companies to bring new products to market. to date, nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies.
NKTR Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 60.40 | 2026-09-28 | -27.84% | -9.538 |
| 1M | 74.19 | 2026-09-04 | -41.25% | -0.995 |
| 3M | 73.15 | 2026-07-06 | -40.42% | 0.701 |
| 6M | 74.72 | 2026-04-06 | -41.67% | 0.667 |
| 1Y | 60.55 | 2025-10-03 | -28.02% | 1.059 |
| 2Y | 19.80 | 2024-10-04 | +120.13% | — |
| 5Y | 271.65 | 2021-10-04 | -83.95% | 1.696 |
NKTR Stock Summary
Nektar Therapeutics (NASDAQ:NKTR) stock price today is $43.59, and today's volume is 2,923,413. NKTR is down 7.246% today. The 30 day average volume is 1.38M. NKTR market cap is $1.49B with 34.14M shares outstanding.